Thor Halfdanarson, Medical Oncologist at the Mayo Clinic, shared a post on X:
“I just posted highly valuable guidelines on MEN1, checked my e-mail and found this… Update in surveillance for VHL.
If you are interested in the NET as a manifestation of MEN1, there is a good chance you might be interested in VHL too… “
Title: Update on Surveillance in Von Hippel-Lindau Disease
Journal: Clinical Cancer Research, AACR
Authors: Surya P. Rednam, Kerri D. Becktell, Anita Villani, Garrett M. Brodeur, Lisa J. States, Andrea S. Doria, Junne Kamihara, Kami Wolfe Schneider, Stephan D. Voss, Elysa Widjaja, Kristin Zelley, Yoshiko Nakano, Kristian W. Pajtler, Maria Isabel Achatz, David Malkin, Lisa R. Diller, Bailey Gallinger, Chieko Tamura, Jonathan D. Wasserman
More posts featuring Thor Halfdanarson on OncoDaily.